Literature DB >> 20667818

A gel-based method for purification of apolipoprotein A-I from small volumes of plasma.

Rachel J Brace1, Brie Sorrenson, Dmitri Sviridov, Sally P A McCormick.   

Abstract

We present here a gel-based method for rapid purification of apolipoprotein A-I (apoA-I) from small volumes of human plasma. After isolation of high density lipoprotein from plasma, the apoA-I protein was separated by electrophoresis and the apoA-I band excised from the gel. The apoA-I was then eluted from the gel strip, concentrated, and delipidated ready for use. The structure and function of the gel-purified apoA-I protein was compared against apoA-I purified by the traditional size-exclusion chromatography method. The α-helical content of the gel-purified apoA-I as determined by circular dichroism was similar to chromatography-purified apoA-I. The functional activity of gel-purified apoA-I, as determined by cholesterol efflux assays in primary human fibroblasts and RAW264.7 macrophages, was also comparable with chromatography-purified apoA-I. This method is a valid alternative for apoA-I purification with some advantages over traditional chromatography purification including a much reduced plasma volume requirement, less time and cost, and a higher percentage protein recovery. The method is particularly suitable for applications requiring the purification of apoA-I from multiple human or animal samples of interest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20667818      PMCID: PMC2952579          DOI: 10.1194/jlr.D008300

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.

Authors:  A Scanu; J Toth; C Edelstein; S Koga; E Stiller
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

3.  Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model.

Authors:  Hiroyuki Saito; Padmaja Dhanasekaran; David Nguyen; Paul Holvoet; Sissel Lund-Katz; Michael C Phillips
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

4.  Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis.

Authors:  E Mortz; T N Krogh; H Vorum; A Görg
Journal:  Proteomics       Date:  2001-11       Impact factor: 3.984

5.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

6.  The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.

Authors:  G Schonfeld; B Pfleger
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

7.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Authors:  Steven E Nissen; Taro Tsunoda; E Murat Tuzcu; Paul Schoenhagen; Christopher J Cooper; Muhammad Yasin; Gregory M Eaton; Michael A Lauer; W Scott Sheldon; Cindy L Grines; Stephen Halpern; Tim Crowe; James C Blankenship; Richard Kerensky
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

8.  Effects of guanidine hydrochloride on human plasma high density lipoproteins.

Authors:  A V Nichols; E L Gong; P J Blanche; T M Forte; D W Anderson
Journal:  Biochim Biophys Acta       Date:  1976-09-28

9.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions.

Authors:  C E Matz; A Jonas
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

10.  Optimized bacterial expression of human apolipoprotein A-I.

Authors:  Robert O Ryan; Trudy M Forte; Michael N Oda
Journal:  Protein Expr Purif       Date:  2003-01       Impact factor: 1.650

View more
  8 in total

1.  A facile method for isolation of recombinant human apolipoprotein A-I from E. coli.

Authors:  Nikita Ikon; Jennifer Shearer; Jianfang Liu; Jesse J Tran; ShiBo Feng; Ayako Kamei; Jennifer A Beckstead; Robert S Kiss; Paul M Weers; Gang Ren; Robert O Ryan
Journal:  Protein Expr Purif       Date:  2017-03-20       Impact factor: 1.650

2.  Affinity binding of chicken apolipoprotein A1 to a novel flax orbitide (linusorb).

Authors:  Pramodkumar D Jadhav; Youn Young Shim; Martin J T Reaney
Journal:  RSC Adv       Date:  2018-05-15       Impact factor: 4.036

3.  Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.

Authors:  Alan R Tall; Nan Wang; Andrew J Murphy; Samuel Funt; Darren Gorman
Journal:  Circ Res       Date:  2013-04-23       Impact factor: 17.367

4.  Functional rescue of mutant ABCA1 proteins by sodium 4-phenylbutyrate.

Authors:  Brie Sorrenson; Rachel J Suetani; Michael J A Williams; Vivienne M Bickley; Peter M George; Gregory T Jones; Sally P A McCormick
Journal:  J Lipid Res       Date:  2012-10-20       Impact factor: 5.922

5.  HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.

Authors:  Huanhuan L Cui; Angela Grant; Nigora Mukhamedova; Tatiana Pushkarsky; Lucas Jennelle; Larisa Dubrovsky; Katharina Gaus; Michael L Fitzgerald; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Lipid Res       Date:  2012-01-19       Impact factor: 5.922

6.  Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Authors:  Monika Sharma; Anne Von Zychlinski-Kleffmann; Carolyn M Porteous; Gregory T Jones; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2015-04-06       Impact factor: 5.922

7.  Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles.

Authors:  Kristen Hong; Minzhi Yu; Julia Crowther; Ling Mei; Karl Olsen; Yonghong Luo; Yuqing Eugene Chen; Yanhong Guo; Anna Schwendeman
Journal:  Pharmaceutics       Date:  2022-07-28       Impact factor: 6.525

8.  Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells.

Authors:  Monika Sharma; Jo Tuaine; Blair McLaren; Debra L Waters; Katherine Black; Lynnette M Jones; Sally P A McCormick
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.